Home Newsfeeds BitNile Chairman/ CEO Tweets ‘Aware Of The Filing Made Yesterday By Our Hosting Provider In Texas. We Have Been In Communication With Them, And Based On Those Discussions, We Have No Reason To Believe It Will Impact Our Mining Operations At The Facili…

News

BitNile Chairman/ CEO Tweets ‘Aware Of The Filing Made Yesterday By Our Hosting Provider In Texas. We Have Been In Communication With Them, And Based On Those Discussions, We Have No Reason To Believe It Will Impact Our Mining Operations At The Facili…

https://twitter.com/ToddAultIII/status/1573325482967416832

byBenzinga Newsdesk

September 23, 2022

1 minute read

Update: $NILE is aware of the filing made yesterday by our hosting provider in Texas. We have been in communication with them, and based on those discussions, we have no reason to believe it will impact our mining operations at the facility. #Bitcoin

— Milton Todd Ault III (@ToddAultIII) September 23, 2022

Johnson & Johnson’s Clock 12% Q4 Revenue Growth, Cancer and Crohn’s Disease Drugs Account as Largest Sellers

By Vandana Singh

January 23, 10:49 AM

Johnson & Johnson's Q4 2023 performance, with adjusted earnings up 11.7%, sales at $21.4 billion, and key insights into pharmaceutical and MedTech segments.

JNJ

Downgrade Aside, Cathie Wood Buys $1.2M Worth Of SoFi Shares

By Benzinga Neuro

July 27, 9:43 PM

On Thursday, Cathie Wood-led Ark Invest made a significant purchase of SoFi Technologies Inc (NASDAQ:SOFI) shares, amidst a…

ACCD

Mullen Inks Class 3 Vehicle Purchase Order With NRTC Automation

By Lekha Gupta

August 28, 11:55 AM

Mullen Automotive Inc (NASDAQ: MULN) disclosed a multiunit vehicle purchase order with NRTC Automation Group (NRTC) to initially buy three all-electric commercial Class 3 Mullen trucks (Mullen THREE), with

MULN

M&A
News

Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction

By Charles Gross

August 1, 7:12 AM

Revolution Medicines, Inc. ("Revolution Medicines" or the "Company") (NASDAQ:RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, and EQRx, Inc.

EQRX

BitNile Chairman/ CEO Tweets ‘Aware Of The Filing Made Yesterday By Our Hosting Provider In Texas. We Have Been In Communication With Them, And Based On Those Discussions, We Have No Reason To Believe It Will Impact Our Mining Operations At The Facili…

Related Posts

Johnson & Johnson’s Clock 12% Q4 Revenue Growth, Cancer and Crohn’s Disease Drugs Account as Largest Sellers

Downgrade Aside, Cathie Wood Buys $1.2M Worth Of SoFi Shares

Mullen Inks Class 3 Vehicle Purchase Order With NRTC Automation

Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction